May 18, 2021 07:20 PM (GMT+8) · EqualOcean
Teyi pharmaceutical announced that it plans to invest 100 million yuan to establish Guangdong Temei Health Technology Industry Co., Ltd. (tentative), which is the investment and operation platform for the big health industry of Teyi Pharmaceutical Group. Its development direction includes the development and investment in the field of medical beauty services. The executive director and manager of the company are Xu ronghuang, the eldest son of Xu Danqing, the current chairman of the company.